MetLife Investment Management’s Celanese CE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $83.9K | Buy |
1,824
+32
| +2% | +$1.85K | ﹤0.01% | 2802 |
|
|
2026
Q1 | $118K | Buy |
1,792
+3
| +0.2% | +$157 | ﹤0.01% | 2466 |
|
|
2025
Q4 | $75.6K | Sell |
1,789
-71
| -4% | -$2.9K | ﹤0.01% | 2682 |
|
|
2025
Q3 | $78.3K | Buy |
1,860
+2
| +0.1% | +$100 | ﹤0.01% | 2738 |
|
|
2025
Q2 | $103K | Sell |
1,858
-1,313
| -41% | -$65.4K | ﹤0.01% | 2527 |
|
|
2025
Q1 | $180K | Sell |
3,171
-26,978
| -89% | -$1.68M | ﹤0.01% | 2259 |
|
|
2024
Q4 | $2.09M | Buy |
30,149
+479
| +2% | +$46K | 0.01% | 1011 |
|
|
2024
Q3 | $4.03M | Buy |
29,670
+1,361
| +5% | +$179K | 0.02% | 653 |
|
|
2024
Q2 | $3.82M | Buy |
28,309
+4,889
| +21% | +$747K | 0.02% | 641 |
|
|
2024
Q1 | $4.02M | Sell |
23,420
-862
| -4% | -$131K | 0.03% | 615 |
|
|
2023
Q4 | $3.77M | Sell |
24,282
-445
| -2% | -$58K | 0.03% | 637 |
|
|
2023
Q3 | $3.1M | Sell |
24,727
-647
| -3% | -$79.5K | 0.02% | 691 |
|
|
2023
Q2 | $2.94M | Sell |
25,374
-543
| -2% | -$58.8K | 0.02% | 760 |
|
|
2023
Q1 | $2.82M | Sell |
25,917
-308
| -1% | -$35.6K | 0.02% | 771 |
|
|
2022
Q4 | $2.68M | Sell |
26,225
-408
| -2% | -$40.5K | 0.02% | 775 |
|
|
2022
Q3 | $2.41M | Sell |
26,633
-2,542
| -9% | -$279K | 0.02% | 798 |
|
|
2022
Q2 | $3.43M | Sell |
29,175
-2,007
| -6% | -$288K | 0.03% | 650 |
|
|
2022
Q1 | $4.45M | Buy |
31,182
+7,129
| +30% | +$1.09M | 0.03% | 611 |
|
|
2021
Q4 | $4.04M | Sell |
24,053
-1,042
| -4% | -$170K | 0.03% | 508 |
|
|
2021
Q3 | $3.78M | Sell |
25,095
-1,017
| -4% | -$157K | 0.03% | 511 |
|
|
2021
Q2 | $3.96M | Sell |
26,112
-1,095
| -4% | -$174K | 0.03% | 516 |
|
|
2021
Q1 | $4.08M | Sell |
27,207
-1,181
| -4% | -$162K | 0.04% | 497 |
|
|
2020
Q4 | $3.69M | Sell |
28,388
-1,604
| -5% | -$199K | 0.03% | 516 |
|
|
2020
Q3 | $3.22M | Sell |
29,992
-928
| -3% | -$92.6K | 0.04% | 504 |
|
|
2020
Q2 | $2.67M | Sell |
30,920
-236
| -0.8% | -$19.7K | 0.03% | 583 |
|
|
2020
Q1 | $2.29M | Sell |
31,156
-954
| -3% | -$94.4K | 0.03% | 554 |
|
|
2019
Q4 | $3.95M | Sell |
32,110
-1,564
| -5% | -$192K | 0.04% | 470 |
|
|
2019
Q3 | $4.12M | Sell |
33,674
-1,225
| -4% | -$138K | 0.05% | 419 |
|
|
2019
Q2 | $3.76M | Sell |
34,899
-74,343
| -68% | -$7.7M | 0.04% | 494 |
|
|
2019
Q1 | $10.8M | Buy |
109,242
+70,990
| +186% | +$6.98M | 0.03% | 507 |
|
|
2018
Q4 | $3.44M | Buy |
38,252
+38,065
| +20,356% | +$3.73M | 0.04% | 452 |
|
|
2018
Q3 | $21.3K | Buy |
+187
| New | +$21.4K | ﹤0.01% | 2380 |
|
Other funds holding CE
MetLife Investment Management's CE Position: Q2 2026 in Review
MetLife Investment Management increased its Celanese (CE) stake by 1.8% in Q2 2026, buying an estimated $1.85K and bringing the position to 1,824 shares worth $83.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2802.
MetLife Investment Management first reported a position in CE in Q3 2018 and has held it in 32 quarters since. The position peaked at $10.8M in Q1 2019. 460 funds tracked by Wall St. Rank hold CE as of Q2 2026.
- MetLife Investment Management held 1,824 shares of Celanese worth $83.9K as of Q2 2026.
- MetLife Investment Management bought 32 Celanese shares in Q2 2026, an estimated $1.85K.
- Celanese made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #2802 holding.
- MetLife Investment Management first reported a position in Celanese in Q3 2018 and has held it in 32 quarters since.
- MetLife Investment Management's Celanese position peaked at $10.8M in Q1 2019.
- 460 funds tracked by Wall St. Rank held Celanese as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.